Respirent is committed to provide Affordable Respiratory Medicines.
For both asthma and chronic obstructive pulmonary disease (COPD) these chronic diseases require daily medications. We recognise the cost burden to patients and health authorities alike around the world. Prevalence and incidence have been increasing worldwide particularly in underprivileged populations. At Respirent, we are dedicated to address a significant unmet need to tackle this growing global public health problem and to create value to the healthcare providers and patients. Respirent’s generic products are developed and manufactured in new state-of-the-art facilities meeting the most stringent regulatory and quality standards defined in US and EU. Our upstream supply partners are global leaders in their field of expertise which ensures our delivery and service to our commercial partners and to our patients is world-class.